Common use of Territory Development Plan Clause in Contracts

Territory Development Plan. Prior to ZLAB’s performance of any Development of the Product in the Territory (other than a Global Trial), the JSC must agree to a Territory Development Plan governing such Development and, for clarity, such Development shall be limited to the Approved Product for an Approved Indication that is specific to the Territory. If ZLAB desires to conduct any such Development during the Term, it shall submit to Regeneron, through the JDC, for review and revision, if applicable, a proposed Territory Development Plan including all of the detail set forth in the last sentence of this Section 5.2, and the JDC shall submit such updated Territory Development Plan to the JSC for approval. ZLAB will review and update the Territory Development Plan at least once annually and will present an updated Territory Development Plan to the JDC for review and revision, if applicable, at least […***…] prior to the end of each Calendar Year (starting in 2020), and the JDC shall submit the Territory Development Plan to the JSC for approval. The Parties will use good faith efforts to cause any updates to the Territory Development Plan to be approved by the JSC at least […***…] prior to the end of each Calendar Year. Each Territory Development Plan will set forth, in a reasonable level of detail, the plan for ZLAB’s Development of the Approved Product for the Approved Indications that is […***…] and will include all details set forth on Schedule 5.2, as well as strategies and timelines for Developing and obtaining and maintaining Regulatory Approvals for the Approved Product for the Approved Indications in the Territory.

Territory Development Plan. Prior Except for the activities [***] pursuant to ZLAB’s performance Section 5.3, all Development by Zai of any Development of the Product Licensed Products in the Territory under this Agreement shall be conducted pursuant to a written development plan (other than a Global Trialas amended from time to time in accordance with this Section 5.4 and Section 3.2, the “Territory Development Plan”), the JSC must agree to a which Territory Development Plan governing shall contain in reasonable detail all major Development activities (including all Clinical Trials) for Licensed Products in the Territory and the timelines for achieving such Development and, for clarity, such Development shall be limited to activities. Attached hereto as Exhibit C is an initial THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL draft of the Approved Product for an Approved Indication that is specific to the Territory. If ZLAB desires to conduct any such Development during the Term, it shall submit to Regeneron, through the JDC, for review and revision, if applicable, a proposed Territory Development Plan including all and attached hereto as Exhibit B is a NMPA Submission Timeline for the indications of recurrent and newly diagnosed GBM. From time to time as needed thereafter, Zai shall propose amendments to the detail set forth Territory Development Plan in the last sentence of this Section 5.2, consultation with NVCR and the JDC shall submit such proposed updated or amended Territory Development Plan to the JSC for review, discussion and approval. ZLAB will review and update Once approved by the JSC, the amended Territory Development Plan shall become effective. For clarity, the Territory Development Plan at least once annually and will present an updated Territory Development Plan to amendments thereto must be consistent with the JDC for review and revision, if applicable, at least […***…] prior to the end of each Calendar Year (starting in 2020), Plan and the JDC [***] Plan shall submit take precedent in case of any conflict or inconsistency between the Territory Development Plan to and the JSC for approval. The Parties will use good faith efforts to cause any updates to the Territory Development Plan to be approved by the JSC at least […***…] prior to the end of each Calendar Year. Each Territory Development Plan will set forth, in a reasonable level of detail, the plan for ZLAB’s Development of the Approved Product for the Approved Indications that is […***…] and will include all details set forth on Schedule 5.2, as well as strategies and timelines for Developing and obtaining and maintaining Regulatory Approvals for the Approved Product for the Approved Indications in the TerritoryPlan.

Territory Development Plan. Prior Except for the activities allocated to ZLAB’s performance Zai under the Global Development Plan pursuant to Section 5.3, all Development by Zai of any Development of the Product Licensed Products in the Territory under this Agreement shall be conducted pursuant to a written development plan (other than a Global Trialas amended from time to time in accordance with this Section 5.4 and Section 3.2, the “Territory Development Plan”), the JSC must agree to a which Territory Development Plan governing shall CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED WITH [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. EXHIBIT 10.15 CONFIDENTIAL contain in reasonable detail all major Development activities (including all Clinical Trials) for Licensed Products in the Territory and the timelines for achieving such Development and, for clarity, such Development shall be limited to activities. Attached hereto as Exhibit C is an initial draft of the Approved Product for an Approved Indication that is specific to the Territory. If ZLAB desires to conduct any such Development during the Term, it shall submit to Regeneron, through the JDC, for review and revision, if applicable, a proposed Territory Development Plan including all and attached hereto as Exhibit B is a NMPA Submission Timeline for the indications of recurrent and newly diagnosed GBM. From time to time as needed thereafter, Zai shall propose amendments to the detail set forth Territory Development Plan in the last sentence of this Section 5.2, consultation with NVCR and the JDC shall submit such proposed updated or amended Territory Development Plan to the JSC for review, discussion and approval. ZLAB will review and update Once approved by the JSC, the amended Territory Development Plan shall become effective. For clarity, the Territory Development Plan at least once annually and will present an updated Territory amendments thereto must be consistent with the Global Development Plan to the JDC for review and revision, if applicable, at least […***…] prior to the end of each Calendar Year (starting in 2020), and the JDC Global Development Plan shall submit take precedent in case of any conflict or inconsistency between the Territory Development Plan to and the JSC for approval. The Parties will use good faith efforts to cause any updates to the Territory Global Development Plan to be approved by the JSC at least […***…] prior to the end of each Calendar Year. Each Territory Development Plan will set forth, in a reasonable level of detail, the plan for ZLAB’s Development of the Approved Product for the Approved Indications that is […***…] and will include all details set forth on Schedule 5.2, as well as strategies and timelines for Developing and obtaining and maintaining Regulatory Approvals for the Approved Product for the Approved Indications in the TerritoryPlan.

Territory Development Plan. Prior Except for the activities allocated to ZLAB’s performance Zai under the Global Development Plan pursuant to Section 5.3, all Development by Zai of any Development of the Product Licensed Products in the Territory under this Agreement shall be conducted pursuant to a written development plan (other than a Global Trialas amended from time to time in accordance with this Section 5.4 and Section 3.2, the “Territory Development Plan”), the JSC must agree to a which Territory Development Plan governing shall THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. 19 EXHIBIT 10.15 CONFIDENTIAL contain in reasonable detail all major Development activities (including all Clinical Trials) for Licensed Products in the Territory and the timelines for achieving such Development and, for clarity, such Development shall be limited to activities. Attached hereto as Exhibit C is an initial draft of the Approved Product for an Approved Indication that is specific to the Territory. If ZLAB desires to conduct any such Development during the Term, it shall submit to Regeneron, through the JDC, for review and revision, if applicable, a proposed Territory Development Plan including all and attached hereto as Exhibit B is a NMPA Submission Timeline for the indications of recurrent and newly diagnosed GBM. From time to time as needed thereafter, Zai shall propose amendments to the detail set forth Territory Development Plan in the last sentence of this Section 5.2, consultation with NVCR and the JDC shall submit such proposed updated or amended Territory Development Plan to the JSC for review, discussion and approval. ZLAB will review and update Once approved by the JSC, the amended Territory Development Plan shall become effective. For clarity, the Territory Development Plan at least once annually and will present an updated Territory amendments thereto must be consistent with the Global Development Plan to the JDC for review and revision, if applicable, at least […***…] prior to the end of each Calendar Year (starting in 2020), and the JDC Global Development Plan shall submit take precedent in case of any conflict or inconsistency between the Territory Development Plan to and the JSC for approval. The Parties will use good faith efforts to cause any updates to the Territory Global Development Plan to be approved by the JSC at least […***…] prior to the end of each Calendar Year. Each Territory Development Plan will set forth, in a reasonable level of detail, the plan for ZLAB’s Development of the Approved Product for the Approved Indications that is […***…] and will include all details set forth on Schedule 5.2, as well as strategies and timelines for Developing and obtaining and maintaining Regulatory Approvals for the Approved Product for the Approved Indications in the TerritoryPlan.